Saturday 17 October 2026
Export SPOK’s income statement to Excel — free account
Spok Holdings, Inc.
SPOK Healthcare Health Information Services
Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024. In the quarter to June 2026, revenue fell 1.89%, EPS fell 9.09% and free cash flow fell 2.00%, each against the same quarter a year earlier. Dividend growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
10.61
0.12
−1.12%
Follow SPOK
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
10.88% | 10.55% | 8.66% | 8.42% | |
Piotroski F-Score |
6 | 6 | 5 | 5 | |
| 7.78% | 7.50% | 6.36% | 6.06% | ||
ROIC |
10.02% | 10.17% | 8.14% | 8.20% | |
Return on Tangible Assets |
102.29% | 109.54% | 136.57% | 126.49% | |
Average Days of Receivables |
67.11 | 59.16 | 52.82 | 63.06 | |
Free Cash Flow per Share |
1.10 | 1.23 | 1.23 | 1.22 | |
Free Cash Flow |
22.62 | 25.20 | 25.53 | 25.41 | |
Capital Expenditures |
(3.21) | (3.75) | (3.61) | (3.17) | |
| Other line items | |||||
Cash ROIC |
13.30% | 14.68% | 16.15% | 16.24% | |
Accounts Receivable Turnover |
5.94 | 6.27 | 6.76 | 5.51 | |
Accounts Payable Turnover |
8.06 | 6.20 | 7.35 | 7.15 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
41.48 | 48.71 | 59.55 | 54.88 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | (0.26) | (0.29) | (0.28) | |
Research and Development Expense of Revenue |
8.51% | 8.74% | 9.21% | 9.41% | |
Selling, General and Administrative Expense of Revenue |
35.20% | 35.44% | 35.74% | 34.75% | |
Share Based Compensation of Revenue |
3.73% | 3.58% | 3.81% | 3.95% | |
Operating CF/Net income |
1.56 | 1.82 | 2.30 | 2.34 | |
Depreciation/Fixed assets |
0.61 | 0.60 | 0.65 | 0.68 | |
Capex/Depreciation |
(0.91) | (1.09) | (1.01) | (0.87) | |
Revenue per Share |
6.79 | 6.80 | 6.58 | 6.51 | |
Operating CF per Share |
1.25 | 1.41 | 1.40 | 1.37 | |
Capex per Share |
(0.16) | (0.18) | (0.17) | (0.15) | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.02 |
Columns are period end dates